Sylvain Thepot
Angers, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 79 publications
Ivosidenib monotherapy in IDH1 mutated myelodysplastic neoplasm/syndrome.
Journal: Leukemia
Published: April 12, 2026
Association between treatment-emergent cytopenias and clinical responses to imetelstat in lower-risk myelodysplastic syndromes.
Journal: Blood cancer journal
Published: February 03, 2026
Mutational dynamics in patients with del(5q) MDS treated with lenalidomide prior to transfusion dependency-Molecular results from the Sintrarev clinical trial.
Journal: HemaSphere
Published: October 08, 2025
Effect of prior therapy on the clinical activity of imetelstat in patients with transfusion-dependent, ESA-relapsed or -refractory/-ineligible LR-MDS.
Journal: Blood cancer journal
Published: September 18, 2025
Clinical outcomes and safety in patients with lower-risk myelodysplastic syndromes treated with imetelstat: Substudy of the phase 3 IMerge trial.
Journal: British journal of haematology
Published: July 29, 2025
Association Between Molecular Profile and Outcome After Intensive Chemotherapy in Patients > 60 Years With Secondary and/or Adverse Cytogenetics Acute Myeloid Leukemia-A FILO Study.
Journal: American journal of hematology
Published: May 20, 2025
Efficacy and safety of luspatercept with or without erythropoiesis-stimulating agent in patients with myelodysplastic neoplasms with ring sideroblasts: A multicentre real-life study by the GFM.
Journal: British journal of haematology
Published: March 28, 2025
Oral decitabine and cedazuridine maintenance after haematopoietic stem-cell transplantation in very high-risk acute myeloid leukaemia or myelodysplastic syndrome (GFM-DACORAL-DLI): a multicentre, single-arm, phase 2 trial.
Journal: The Lancet. Haematology
Published: March 24, 2025
Last Updated: 09/26/2026